CALGB 50401: A randomized trial of lenalidomide alone versus lenalidomide plus rituximab in patients with recurrent follicular lymphoma.
- Citation:
- J Clin Oncol vol 30 (15 suppl) abstr 80000
- Meeting Instance:
- ASCO 2012
- Year:
- 2012
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2102
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- J. Leonard S.-H. Jung J. L. Johnson N. L. Bartlett K. A. Blum B. D. Cheson
- Networks:
- Study
- CALGB-50401
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: